PubRank
Search
About
G Fioritoni
Author PubWeight™ 24.30
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.
Blood
2000
3.07
2
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
Blood
1997
1.53
3
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Br J Cancer
2004
1.11
4
Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia.
J Clin Microbiol
1994
0.98
5
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
Leukemia
2011
0.97
6
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.
Leukemia
2011
0.92
7
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
Leukemia
2003
0.92
8
Treatment of adults with acute lymphoblastic leukaemia in first bone marrow relapse: results of the ALL R-87 protocol.
Br J Haematol
1997
0.92
9
Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
Cancer Res
1980
0.82
10
Complex chromosome translocations of standard t(8;21) and t(15;17) arise from a two-step mechanism as evidenced by fluorescence in situ hybridization analysis.
Cancer Genet Cytogenet
1996
0.81
11
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.
Haematologica
2000
0.80
12
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
J Antimicrob Chemother
1994
0.80
13
Central nervous system acute promyelocytic leukaemia: a report of three cases.
Haematologia (Budap)
1989
0.79
14
Improved collection of granulocytes by modified continuous flow filtration leukapheresis technique.
Haematologica
1980
0.78
15
Hepatosplenic infection caused by Candida parapsilosis in patients with acute leukemia.
Mycoses
1993
0.78
16
Chromosome changes in 19 patients with Waldenström's macroglobulinemia.
Cancer Genet Cytogenet
1987
0.78
17
Meningitis due to penicillin-resistant Streptococcus pneumoniae in patients with chronic graft-versus-host disease.
Bone Marrow Transplant
1992
0.77
18
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.
Blood
2000
0.77
19
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
Chemotherapy
2004
0.77
20
Superficial inflammatory and primary neoplastic lymphadenopathy: diagnostic accuracy of power-doppler sonography.
Eur J Radiol
2004
0.77
21
Evaluation of four different methods for platelet freezing. In vitro and in vivo studies.
Vox Sang
1992
0.76
22
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora.
J Antimicrob Chemother
1996
0.76
23
Human bone marrow processing using Cobe 2991 and CS 3000 blood cell separators for further ex vivo manipulation.
Haematologica
1990
0.76
24
Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation.
Chemotherapy
1992
0.76
25
Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a multicentre retrospective study.
Br J Haematol
1994
0.76
26
Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients.
Drugs Exp Clin Res
1992
0.75
27
Bone marrow transplantation for adult patients with thalassemia major.
Bone Marrow Transplant
1991
0.75
28
Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy.
Intern Med J
2009
0.75
29
Specific esterase activity induced in mouse Friend erythroleukemia cells by dimethylsulfoxide.
J Cell Physiol
1979
0.75
30
Seven-day storage of single donor platelets in polyolefin bags: clinical, biochemical, morphological and microbiological evaluation.
Int J Artif Organs
1988
0.75
31
Karyotypic changes identified by HaeIII restriction endonuclease banding in a patient with M2 acute non-lymphoblastic leukemia.
Genes Chromosomes Cancer
1990
0.75
32
A cytogenetic survey of 13 patients with acute lymphocytic leukemia (ALL).
Haematologica
1988
0.75
33
Chronic granulocytic leukemia with loss of Philadelphia chromosome and development of a Philadelphia negative diploid clone.
Haematologica
1984
0.75
34
Autologous blood stem cell transplantation in hematological malignancies. The Italian experience. Italian Cooperative Study Group.
Bone Marrow Transplant
1990
0.75
35
Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
J Chemother
1989
0.75
36
Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
Drugs Exp Clin Res
1991
0.75
37
[The allograft in acute lymphoblastic leukemia].
Haematologica
1989
0.75
38
Allogeneic bone marrow transplantation for Fanconi anemia.
Bone Marrow Transplant
1992
0.75
39
Detection of bacterial contamination in bone marrow graft.
Haematologica
1991
0.75
40
Portal venous thrombosis in a young patient with idiopathic myelofibrosis and intrahepatic extramedullary hematopoiesis: a difficult diagnosis, prognosis and management.
Leukemia
2007
0.75
41
Prognostic value of atypical chromosomal changes during chronic myeloid leukemia.
Haematologica
1988
0.75
42
A new case of chronic myelogenous leukemia with 14q+ marker and review of the literature.
Ann Genet
1988
0.75
43
Physiopathologic aspects of anemia in thalassemia intermedia.
Haematologica
1986
0.75
44
Erythrokinetics and mechanisms of anaemia in hereditary elliptocytosis and hereditary ovalocytosis.
Haematologica
1982
0.75
45
Therapy of acute myelogenous leukemia in adults.
Haematol Blood Transfus
1990
0.75
46
Autologous blood stem cell collection after chemotherapy in patients with sensitive and refractory malignancies: a multicenter retrospective study.
Int J Artif Organs
1993
0.75
47
Early hematopoietic reconstitution after autologous transplantation with blood-derived stem cells in a patient with advanced lymphoma.
Int J Artif Organs
1989
0.75
48
Autologous blood stem cell transplantation in malignant lymphomas: an Italian Cooperative Study.
Leuk Lymphoma
1992
0.75
49
Philadelphia (Ph), 14q+ and 1q+ chromosomes in immunoblastic phase (Richter's syndrome) in a patient with T chronic lymphocytic leukaemia.
Haematologica
1986
0.75
50
Patterns of infection in 41 patients with idiosyncratic drug-induced agranulocytosis.
Ann Hematol
1991
0.75
51
Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir).
J Chemother
1991
0.75
52
Occurrence of bacteremia in hematologic patients.
Eur J Epidemiol
1992
0.75
53
Chromosome abnormalities in PHA-stimulated and non stimulated bone marrow cultures from patients with non Hodgkin lymphoma.
Haematologica
1989
0.75
54
Quantitation of the ultraviolet light test for erythrocyte glucose 6-phosphate dehydrogenase, pyruvate kinase and glutathione reductase.
Clin Chim Acta
1973
0.75
55
A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
Bone Marrow Transplant
1989
0.75
56
Infection after autologous blood-derived stem cell transplantation.
Haematologica
1990
0.75
57
Cytogenetics and acute non lymphocytic leukemia.
Ann Genet
1987
0.75
58
Hereditary haemolytic ovalocytosis with defective erythropoiesis.
Br J Haematol
1979
0.75
59
Splenectomy in early chronic myeloid leukaemia: preliminary report on 37 cases.
Haematologica
1974
0.75
60
Improvement in the therapy of acute lymphoblastic leukaemia in children.
Haematologica
1985
0.75
61
Remission-induction, consolidation and maintenance therapy by AVA protocol in acute nonlymphoblastic leukemia.
Haematologica
1982
0.75
62
A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA.
Ann Hematol
1992
0.75
63
Enhancement of BMT management in children and adults.
Bone Marrow Transplant
1989
0.75
64
[Erythrocyte volumetric distribution as simple and rapid test in screening for carriers of beta and alfa-thalassemic trait (author's transl)].
Haematologica
1979
0.75
65
Intensification in post-remission treatment of adult acute non lymphocytic leukemia.
Haematologica
1990
0.75
66
Cytogenetic survey of 80 patients with acute nonlymphocytic leukemia.
Cancer Genet Cytogenet
1992
0.75
67
Large volume leukapheresis with AMICUS cell separator in peripheral blood stem cell autologous transplant.
Transfus Apher Sci
2001
0.75
68
Survival after PBSC transplantation and comparison of engraftment speed with autologous and allogeneic marrow transplantation: results of a multicenter study.
Int J Artif Organs
1993
0.75